Less Ads, More Data, More Tools Register for FREE

Pin to quick picksItaconix Plc Regulatory News (ITX)

Share Price Information for Itaconix Plc (ITX)

Share Price is delayed by 15 minutes
Get Live Data
113.50    0.00 (0.00%)
Bid:
110.00
Ask:
117.00
Spread: 7.00 (6.364%)
Market Cap: £15.31m
ITX Live PriceLast checked at - London Stock Exchange

Intraday Itaconix Plc Share Chart

Trading Statement

27 Jul 2021 07:00

RNS Number : 5181G
Itaconix PLC
27 July 2021
 

Strictly embargoed for 07.00, 27 July 2021

Itaconix plc

 

("Itaconix" or "the Company")

 

Trading Update

 

Itaconix plc (AIM: ITX) (OTCQB: ITXXF), a leading innovator in sustainable plant-based polymers used as essential ingredients in everyday consumer products, provides the following update on trading for the half year to 30 June 2021.

 

Further to the update given on 8 June 2021, the Company is pleased to report that growth in demand for its plant-based polymers has continued. Unaudited revenues for the first six months of the year were $1.4 million, representing 26% growth over the equivalent period in 2020 and a 36% decline from the second half of 2020. Revenues for the first half of the year were anticipated to be lower than the second half of 2020 due to the order patterns of major customers. As a result of the overall increase in revenues, unaudited LBITDA(1) was in line with management's expectations.

 

Revenue growth for the period was led by strong product volumes in odour control applications with new and recurring orders spread across North America, Europe, and Asia driven by the success of customer products. The Company plans to add a new odour control product, expand into at least one new application, and increase marketing efforts with broader promotional activities in the second half of 2021.

 

As highlighted in the Company's trading update announced on 8 June 2021, order fluctuations are occurring in detergent applications as brands and retailers adjust inventories due to uncertainties around consumer buying habits, as countries emerge from Covid-19 lockdowns. As a result, unaudited revenues in this area for the first half of 2021 were flat compared to the first half of 2020 due to a sharp decline in monthly volumes at the end of the period.

 

Interest in new detergent products based on Itaconix® TSI™ continues, with new detergent brands and new formulation projects starting by the end of 2021. The Board remains confident in the sizeable revenue potential from current and new customer projects but expects order fluctuations to continue in the second half.

 

Revenues in personal care applications for the period were less than the same period in 2020 and substantially less than the second half of 2020 as shipments in the last part of 2020 were sufficient to meet customer needs during the lockdowns in North America and Europe. The Board anticipates some further delays in new orders but remains confident of the overall major market potential for Itaconix ingredients, particularly as the Company develops new products and increases marketing efforts to accelerate revenues from personal care.

 

As has been widely reported, the delivery costs and times for key raw materials are increasing as suppliers continue to struggle with shipping delays caused by the Covid-19 pandemic and disruption throughout the supply chain. The Company has implemented product price increases and adjusted raw material purchasing and inventories to assure supply and mitigate potential further cost increases.

 

The net proceeds from the recent $1.5 million fundraise have been used for additional working capital, in particular to improve the cost and certainty of the Company's raw material and finished goods supply chain, given the current volatility in this area. The fundraise strengthened the Company's balance sheet and net cash at 30 June 201 was $1.4 million.

 

John R. Shaw, CEO of Itaconix, commented:

 

"We continue to make significant progress capitalising on the revenue potential in every household for our plant-based technologies. Supply chain delays with both our customers and our suppliers are causing some short-term issues, but our revenue opportunities are growing through the increasing recognition of the value of our ingredients in sustainable consumer products and through new additions to our offering of plant-based products. Underlying consumer demand for these products also remains strong."  

 

1 Loss before interest, tax, depreciation and amortisation

 

 

- ends -

 

Enquiries:

 

Itaconix

+1 (603) 775 4400

John R. Shaw / Laura Denner

 

 

 

 

 

 

Belvedere Communications

+44 (0) 20 3687 2756

John West / Llew Angus

 

 

 

N+1 Singer

+44 (0) 207 496 3000

Peter Steel / James Moat (Corporate Finance)

Tom Salvesen (Corporate Broking)

 

 

 

 

 

This announcement contains information which, prior to its disclosure, was inside information as stipulated under the UK version of article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

 

Notes to Editors

 

Itaconix develops and produces bio-based specialty polymers that improve the safety, performance and sustainability of consumer and industrial products, with technology and market leading positions in non-phosphate detergents, odour control, and hair styling.

www.itaconix.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEAKXKASEFEFA
Date   Source Headline
30th Mar 20217:00 amRNSFull Year Results Ended 31 December 2020
24th Mar 202111:06 amRNSSecond Price Monitoring Extn
24th Mar 202111:00 amRNSPrice Monitoring Extension
24th Mar 20217:00 amRNSNotice of Final Results and Investor Presentation
23rd Mar 20212:06 pmRNSSecond Price Monitoring Extn
23rd Mar 20212:00 pmRNSPrice Monitoring Extension
23rd Mar 202111:05 amRNSSecond Price Monitoring Extn
23rd Mar 202111:00 amRNSPrice Monitoring Extension
28th Jan 20212:06 pmRNSSecond Price Monitoring Extn
28th Jan 20212:01 pmRNSPrice Monitoring Extension
27th Jan 202111:06 amRNSSecond Price Monitoring Extn
27th Jan 202111:00 amRNSPrice Monitoring Extension
26th Jan 202111:05 amRNSSecond Price Monitoring Extn
26th Jan 202111:00 amRNSPrice Monitoring Extension
26th Jan 20217:00 amRNSTrading Update for the year ended 31 December 2020
21st Jan 202111:05 amRNSSecond Price Monitoring Extn
21st Jan 202111:01 amRNSPrice Monitoring Extension
18th Jan 20212:06 pmRNSSecond Price Monitoring Extn
18th Jan 20212:01 pmRNSPrice Monitoring Extension
14th Jan 20214:41 pmRNSSecond Price Monitoring Extn
14th Jan 20214:35 pmRNSPrice Monitoring Extension
14th Jan 20212:06 pmRNSSecond Price Monitoring Extn
14th Jan 20212:01 pmRNSPrice Monitoring Extension
14th Jan 20217:00 amRNSAppointment of new Vice President, Operations
8th Jan 202111:06 amRNSSecond Price Monitoring Extn
8th Jan 202111:00 amRNSPrice Monitoring Extension
30th Dec 202011:05 amRNSSecond Price Monitoring Extn
30th Dec 202011:00 amRNSPrice Monitoring Extension
29th Dec 20204:41 pmRNSSecond Price Monitoring Extn
29th Dec 20204:36 pmRNSPrice Monitoring Extension
3rd Nov 20207:00 amRNSAppointment of New Marketing and Sales Executive
28th Oct 20207:00 amRNSHalf Year Results
23rd Oct 20202:30 pmRNSResult of AGM
21st Oct 20207:00 amRNSNotice of Interim Results
13th Oct 202011:06 amRNSSecond Price Monitoring Extn
13th Oct 202011:00 amRNSPrice Monitoring Extension
2nd Oct 20204:35 pmRNSPrice Monitoring Extension
2nd Oct 20203:17 pmRNSCorrection to Full Year Results
30th Sep 20207:00 amRNSFull Year Results
16th Sep 20208:00 amRNSHolding(s) in Company
15th Sep 20207:00 amRNSNotice of Results
22nd Jul 20207:14 amRNSH1 2020 Trading Update
17th Jul 20201:36 pmRNSHolding(s) in Company
17th Jul 202011:18 amRNSHolding(s) in Company
15th Jul 20203:04 pmRNSDirector/PDMR Shareholding
14th Jul 202012:51 pmRNSResult of General Meeting
26th Jun 20206:01 pmRNSNotice of GM and Posting of Circular
24th Jun 20203:33 pmRNSResult of Fundraise
24th Jun 20207:55 amRNSClose of Accelerated Bookbuild
23rd Jun 20205:31 pmRNSLaunch of Fundraise

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.